Skip to main content
. 2017 Feb 27;109(8):djw341. doi: 10.1093/jnci/djw341

Figure 1.

Figure 1.

Biomarker panel performance in the TexGen cohort 1. Receiver operating characteristic (ROC) curves of the biomarker panel in differentiating stage I/IIA (A), stage IIB (B), all stage II (C) and all early-stage cancer (D) from healthy controls in the TexGen cohort. Area under the curve was calculated, and its 95% confidence interval was estimated using bootstrapping method. The P values were two-sided and are based on bootstrapping. CI = confidence interval; TFPI = tissue factor pathway inhibitor; TNC = tenascin C.